NPC1L1 and cancer: Although no dedicated studies have described the relationship between ezetimibe and the risk of cancer or the prognosis of cancer, it is reported that the high expression of NPC1L1, the target of ezetimibe, is associated with the development and prognosis of colorectal cancer, indicating the potential of ezetimibe in the treatment and prevention of cancer (Kwon et al., 2021).